Ekso Bionics Holdings Inc (NAS:EKSO)
$ 0.61 0.005 (0.83%) Market Cap: 13.31 Mil Enterprise Value: 11.08 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 60/100

Ekso Bionics Holdings Inc at HC Wainwright Investment Conference - New York Transcript

Sep 13, 2023 / 08:00PM GMT
Release Date Price: $0.76 (+3.12%)
Swayampakula Ramakanth
H.C. Wainwright & Co. - Analyst

Good afternoon, and thanks for joining us to have a conversation with Scott Davis, President and CEO; and Jerome Wong, CFO of Ekso Bionics. Ekso is developing and commercializing exoskeletons that are used either in neurorehabilitation or increased productivity and reduced injury in sectors such as construction that require repeated action.

Management recently acquired exoskeletons from Parker Hannifin to discuss their products and their current and expected commercial growth. Let's get started with Scott and Jerome.

So thank you for joining us today and taking our invitation to talk to our audience today.

Scott Davis
Ekso Bionics Holdings, Inc. - President & CEO

You bet.

Questions & Answers

Swayampakula Ramakanth;Scott Davis
H.C. Wainwright & Co. - Analyst

So Scott, for starters, help us understand what are exoskeletons and how are they being used in inpatient rehabilitation these days?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot